跳至主要内容
临床试验/IRCT20160528028120N1
IRCT20160528028120N1已完成2 期

Gasttro-Resistant Capsules of synbiotic Reduced blood uremic toxins in hemodialysis patients: double-blind placebo-controlled randomized clinical trial.

Isfahan university of medical sciences; research assistant part0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • performing hemodialysis treatment 3-times per week for at least 4 hours each time,
  • not being pregnant or lactating
  • no history of active cancers (except for skin cancer)
  • no history of severe chronic conditions such as pulmonary, cardiovascular, and hepatic diseases
  • lack of gastrointestinal disorders, HIV disease, and psychiatric problems

排除标准

  • those who used symbiotic, probiotic, prebiotic or antibiotics during 4 weeks preceding the study
  • those who used immune suppressive medicines, and anticoagulant agents
  • with severe edema
  • addiction to alcohol or drugs abuse
  • did not respond to the questions honestly
  • and reported any side effects due to synbiotic consumption

研究者

发起方
Isfahan university of medical sciences; research assistant part

相似试验

Symbiotic and blood uremic toxins in hemodialysis... | 临床试验